Search Results - "Scielzo, C"

Refine Results
  1. 1

    Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions by Bertilaccio, M T S, Scielzo, C, Simonetti, G, Ten Hacken, E, Apollonio, B, Ghia, P, Caligaris-Cappio, F

    Published in Leukemia (01-03-2013)
    “…Xenotransplantation of human tumor cells into immunodeficient mice has been a powerful preclinical tool in several hematological malignancies, with the notable…”
    Get full text
    Journal Article
  2. 2

    The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia by Scielzo, C, Apollonio, B, Scarfò, L, Janus, A, Muzio, M, ten Hacken, E, Ghia, P, Caligaris-Cappio, F

    Published in Leukemia (01-11-2011)
    “…Malignant B lymphocytes from chronic lymphocytic leukemia (CLL) patients maintain the capacity to respond to CD40 ligation, among other microenvironmental…”
    Get full text
    Journal Article
  3. 3

    An overview of chronic lymphocytic leukaemia biology by Bertilaccio, M.T.S., PhD, Scielzo, C., PhD, Muzio, M., PhD, Caligaris-Cappio, F

    “…Chronic lymphocytic leukaemia (CLL) is characterised by accumulation of CD5+ monoclonal B cells in primary and secondary lymphoid tissues. Genetic defects and…”
    Get full text
    Journal Article
  4. 4

    ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage by SCIELZO, C, CAMPOREALE, A, GEUNA, M, ALESSIO, M, POGGI, A, ZOCCHI, M. R, CHILOSI, M, CALIGARIS-CAPPIO, F, GHIA, P

    Published in Leukemia (01-04-2006)
    “…ZAP-70 tyrosine kinase is involved in signalling pathways following T-cell receptor stimulation and was originally described only in T cells and natural killer…”
    Get full text
    Journal Article
  5. 5

    The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia by Scielzo, C, Apollonio, B, Scarfò, L, Janus, A, Muzio, M, Ten Hacken, E, Ghia, P, Caligaris-cappio, F

    Published in Leukemia (01-11-2011)
    “…Malignant B lymphocytes from chronic lymphocytic leukemia (CLL) patients maintain the capacity to respond to CD40 ligation, among other microenvironmental…”
    Get full text
    Journal Article
  6. 6

    Differential effects on CLL cell survival exerted by different microenvironmental elements by Ghia, P, Circosta, P, Scielzo, C, Vallario, A, Camporeale, A, Granziero, L, Caligaris-Cappio, F

    “…Selected microenvironmental stimuli confer to leukemic cells a growth advantage and an extended survival. We aimed at dissecting the differential support…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly by Ghia, Paolo, Prato, Giuseppina, Scielzo, Cristina, Stella, Stefania, Geuna, Massimo, Guida, Giuseppe, Caligaris-Cappio, Federico

    Published in Blood (15-03-2004)
    “…The responsiveness and diversity of peripheral B-cell repertoire decreases with age, possibly because of B-cell clonal expansions, as suggested by the…”
    Get full text
    Journal Article
  11. 11

    The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression by Ghia, Paolo, Guida, Giuseppe, Stella, Stefania, Gottardi, Daniela, Geuna, Massimo, Strola, Giuliana, Scielzo, Cristina, Caligaris-Cappio, Federico

    Published in Blood (15-02-2003)
    “…Chronic lymphocytic leukemia (CLL) has a variable clinical course. CD38 expression and IgVH gene mutational status are independent predictors of prognosis, but…”
    Get full text
    Journal Article
  12. 12

    CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes by Granziero, Luisa, Circosta, Paola, Scielzo, Cristina, Frisaldi, Elisa, Stella, Stefania, Geuna, Massimo, Giordano, Silvia, Ghia, Paolo, Caligaris-Cappio, Federico

    Published in Blood (01-03-2003)
    “…Growth and survival of chronic B-cell tumors are favored by the malignant cell's capacity to respond to selected microenvironmental stimuli provided by…”
    Get full text
    Journal Article
  13. 13

    HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses by Scielzo, Cristina, Ghia, Paolo, Conti, Antonio, Bachi, Angela, Guida, Giuseppe, Geuna, Massimo, Alessio, Massimo, Caligaris-Cappio, Federico

    Published in The Journal of clinical investigation (01-06-2005)
    “…We used a proteomic approach for identifying molecules involved in the pathogenesis of chronic lymphocytic leukemia (CLL). We investigated 14 patients who were…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Erratum: The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia by Scielzo, C, Apollonio, B, Scarfò, L, Janus, A, Muzio, M, ten Hacken, E, Ghia, P, Caligaris-Cappio, F

    Published in Leukemia (09-11-2011)
    “…Correction to: Leukemia (2011) 25, 1760–1767; doi:10.1038/leu.2011.149 Since the publication of this article, the authors of the above paper have noticed…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20